347 results on '"Almond, C."'
Search Results
2. Improved Metrics After Implementation of a Clinical Stroke Pathway for Children on Ventricular Assist Devices
3. A Pediatric Heart Failure Registry: The Time for Action is Now
4. Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation
5. Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant
6. Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
7. Associations between antibiotic prescriptions and recurrent urinary tract infections in female college students
8. (324) Stanford Pediatric Psychosocial Optimization Tool for Transplant
9. (1038) Racial Disparities in the Use of Ventricular Assist Devices (VADs) in US Children Listed for Heart Transplantation
10. (322) A Pediatric Heart Failure Registry is Needed: A Time for ACTION
11. Impact of the 2018 Adult Heart Allocation Change on Pediatric Donor Offers and Waitlist Outcomes
12. Immunosuppressant Drug Level Monitoring in Pediatric Heart Transplant Recipients: A Report from the TEAMMATE Trial
13. Major Adverse Dystrophinopathy Event Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy
14. A Novel Approach to Pediatric Heart Failure Quality Improvement within the ACTION Network
15. (1370) - Exploring Factors Associated with Prolonged Intubation After Ventricular Assist Device Implantation in Children
16. (1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
17. (1363) - Improved Metrics After Implementation of a Clinical Stroke Pathway for Children on Ventricular Assist Devices
18. (1340) - Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant
19. (1331) - A Pediatric Heart Failure Registry: The Time for Action is Now
20. (221) - Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation
21. Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?
22. Valutazione economica del trattamento con impianto intravitreale biodegradabile di desametasone di pazienti affetti da edema maculare secondario a occlusione della vena retinica, in Italia
23. Impact of Institutional Routine Endomyocardial Surveillance Biopsy Practices on Rejection and Graft Survival in Pediatric Heart Transplantation
24. Association between Pre-Albumin and Malnutrition in Children with Advanced Heart Failure
25. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances
26. A Risk-Prediction Model for In-hospital Mortality After Heart Transplantation in US Children
27. (397) Use of the SherpaPak Cardiac Transport System for Infant and Pediatric Donor Hearts: An Initial Experience
28. (323) Suboptimal Titration of Heart Failure Medications in Pediatric Patients: Baseline Data from the ACTION Network
29. (1034) Racial and Geographic Disparities in Utilization of Listing by Exception Among US Children Listed for Heart Transplantation
30. (1036) Through the "Chimney": Berlin Heart Excor Pediatric Ventricular Assist Device Inflow Stenting via a Novel Direct Access to Inflow Tubing
31. Trends in Wait–List Mortality in Children Listed for Heart Transplantation in the United States: Era Effect Across Racial/Ethnic Groups
32. Improved Survival in Pediatric Heart Transplant Recipients: Have White, Black and Hispanic Children Benefited Equally?
33. PCN68 An Incremental Effectiveness Analysis of Lorlatinib for the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer that has Progressed after Another ALK Tyrosine Kinase Inhibitor in Portugal
34. PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece
35. Association between Pre-Albumin and Malnutrition in Children with Advanced Heart Failure
36. Impact of High- vs. Low-Frequency Surveillance Endomyocardial Biopsy Strategy in Pediatric Heart Transplantation
37. The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial
38. Impact of Insurance Status on Pediatric Heart Transplant Recipients
39. Conversion from Compounded Liquid Prograf to Prograf Granules - Lessons Learned from Our Early Experience
40. Racial and Ethnic Differences in Mortality in Children Awaiting Heart Transplant in the United States
41. New heterocyclic systems containing nitrogen
42. PNS260 INCLUSION OF NEW STRATEGIES IN THE UK'S CANCER DRUG FUND: WHAT WAS DECIDED IN FRANCE?
43. Palliative Care Involvement in Pediatric VAD Patients - A Single Center Experience
44. Readmissionsfor Children Hospitalized with Heart Failure: Are Some ReadmissionsPreventable?
45. The First Analysis of the International Pediatric Heart Failure Registry (iPHFR) - Heart Failure Hospitalizations
46. The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden
47. Surgical Strategy to Support Right Ventricle with HVAD RVAD: Right Atrial vs Right Ventricular Diaphragmatic Surface Cannulation
48. Impact of Left Ventricular Assist Device on End-Organ Function in US Children Awaiting Heart Transplant
49. Safety Problems Associated with Extemporaneously-Prepared Liquid Tacrolimus in US Children After Heart Transplantation
50. Compassionate Deactivation of Ventricular Assist Devices in Children: A Survey of Pediatric VAD Clinicians’ Perspectives and Practices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.